Nivolumab and Eribulin in HER2 Negative Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Copanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Pyrotinib in Combination With Fulvestrant in Patients With HER2 Positive，HR-Positive Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE4
Implementing Patients´ Competence in Oral Breast Cancer Therapy
- Status
- UNKNOWN
- Phase
- N/A
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- Status
- RECRUITING
- Phase
- NA
A Study of TAS-120 in Patients With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
- Status
- RECRUITING
- Phase
- PHASE1
Capecitabine in Combination With Aromatase Inhibitor Versus Aromatase Inhibitors, in Hormonal Receptor Positive Recurrent or Metastatic Breast Cancer Patients, Randomized Controlled Study
- Status
- UNKNOWN
- Phase
- PHASE2
Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Telephone Support for Metastatic Breast Cancer Patients
- Status
- COMPLETED
- Phase
- NA
A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of CDK4/6 Inhibitor SHR6390 Combined With Pyrotinib in the Treatment of HER2-positive Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE4
Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Nurse AMIE: Addressing Metastatic Individuals Everyday
- Status
- COMPLETED
- Phase
- NA
Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases
- Status
- TERMINATED
- Phase
- NA
A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body
- Status
- COMPLETED
- Phase
- PHASE1
ORIN1001 in Patients with Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2